Search Results for “Get instant Success With SAP C-C4H630-34 Exam Questions [2024] 🎯 Simply search for 【 C-C4H630-34 】 for free download on ➥ www.pdfvce.com 🡄 🏃Exam C-C4H630-34 Flashcards” – Page 7

Innate immunity and allergy in the skin

32.	Metz, M. and Maurer, M.: Innate immunity and allergy in the skin. Curr. Opin. Immunol. 2009: 21; 687-693. IF: 10.88

127	Vukman, K. V., Visnovitz, T., Adams, P. N., Metz, M., Maurer, M. and O’Neill, S. M.+: Mast cells cultured from IL-3 treated mice show impaired responses to bacterial antigen stimulation. Inflamm. Res. 2012: 61; 79-85. IF: 1.96

55.	Buddenkotte, J., Maurer, M., and Steinhoff, M.: Histamine and antihistamines in atopic dermatitis. Adv. Exp. Med. Biol. 2011: 709; 73-80. IF: 1.37

Comparison of urticaria activity score over 7 days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study

303

Hollis, K.+, Proctor, C., McBride, D., Balp, M. M., McLeod, L., Hunter, S., Tian, H., Khalil, S., and Maurer, M.: Comparison of urticaria activity score over 7 days (UAS7) values obtained from once-daily and twice-daily versions: results from the ASSURE-CSU study. Am. J. Clin. Dermatol. 2018: 19; 267-274. IF: 3.84

A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency

390.

Vatsiou, S., Zamanakou, M., Loules, G., Psarros, F., Parsopoulou, F., Csuka, D., Valerieva, A., Staevska, M., Porebski, G., Obtulowicz, K., Magerl, M., Maurer, M., Speletas, M., Farkas, H., and Germenis, A. E.⁺: A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency. Allergol. Int. 2020: 69; 443-449. IF: 5.84

o.390

102.	Kolkhir, P., Pogorelow, D., Olisova, O., and Maurer, M.+: Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus – a systemic review. Clin. Exp. Allergy 2016: 46; 275-287. IF: 5.26

The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: a UCARE study

407.

Maurer, M.⁺, Weller, K., Magerl, M., Maurer, R. R., Vanegas, E., Felix, M., Cherrez, A., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Dheeraj, N., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., van Doorn, M., Or Valle, S., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Benavides, E. E. M., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z.-T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., and Cherrez-Ojeda, I.: The usage, quality and relevance of information and communications technologies in patients with chronic urticaria: a UCARE study. World Allergy Organ. J. 2020: 13; 100475. IF: 4.08

o.407

378	Fricke, J.+, Ávila, G., Keller, T., Weller, K., Lau, S., Maurer, M., Zuberbier, T., and Keil, T.: Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy 2020: 75; 423-432. IF: 13.15

o.378

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcɛRI-positive cells in the skin

269

Metz, M., Staubach, P., Bauer, A., Brehler, R., Gericke, J., Kangas, M., Ashton-Chess, J., Jarvis, P., Georgiou, P., Canvin, J., Hillenbrand, R., Erpenbeck, V. J., and Maurer, M.+: Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcɛRI-positive cells in the skin. Theranostics 2017: 7; 1266-1276. IF: 8.54

326	Riedl, M.+, Farkas, H., Bernstein, J. A., Bouillet, L., Sheridan, W. P., and Maurer, M.: Evaluation of avoralstat, an oral kallikrein inhibitor, in a phase 3 hereditary angioedema prophylaxis trial: the OPuS-2 study. Allergy 2018: 73; 1871-1880. IF: 6.77

Results